These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2005-001701-26 First- Line Treatment of Postmenopausal Patients with Endocrine Responsive Metastatic Breast Cancer. A Randomized, Multicenter Study Comparing Letrozole Combined with Standard Chemotherapy Vs Letrozol... 2008-02-28 due-trials
Not reported 2007-005022-71 Prospective randomized Phase II trial with gemcitabine plus sunitinib versus gemcitabine alone in first-line therapy of metastatic or locally advanced pancreatic cancer 2011-11-08 due-trials
Not reported 2008-001515-37 A prospective angiogenic imaging study with DCE-MRI and DCE-USI in patients with colorectal cancer and liver metastases receiving sunitinib in addition to 5-FU, folinic acid and irinotecan (FOLFIRI) ... 2010-07-12 due-trials
Completed, but no date Terminated 2009-010143-13 Prospective randomized phase-II trial with Temsirolimus versus Sunitinib in previously untreated patients with advanced or metastatic non-clear cell renal carcinoma bad-data
Exempt 2010-018370-21 Phase I/II study with Temsirolimus versus no add-on in patients with castration resistant prostate cancer (CRPC) receiving first-line Docetaxel chemotherapy 2014-09-25 not-yet-due
Reported results 2010-023688-16 An Open-Label, Randomized, Parallel Group Study of Patients Treated with Paclitaxel with Standard Dosing versus Pharmacokinetic Guided Dose Adjustment in Patients with Advanced NSCLC 2014-12-25 due-trials
Reported results 2011-003553-26 A single arm study in metastatic colorectal cancer patients treated with pharmacokinetically (PK) dose adjusted weekly or biweekly 5-fluorouracil (5-FU) regimes. 2014-09-17 due-trials
Completed, but no date Terminated 2011-005939-78 A prospective, open-label, multicenter, randomized phase II trial: bad-data
Ongoing, reported early 2012-001415-23 A single arm Pharmacokinetic/Pharmacodynamic Study of Sunitinib and Pazopanib in Patients with Metastasized Renal Cell Carcinoma not-yet-due
Ongoing 2013-005504-34 Randomized phase II CAbazitaxel dose Individualization and Neutropenia prevention TriAl (CAINTA) not-yet-due
Ongoing 2017-003780-35 Randomized phase II, open-label efficacy and safety study of second-line platinum-based chemotherapy followed by durvalumab (MEDI4736) plus tremelimumab versus platinum-based chemotherapy alone in pat... not-yet-due